Page last updated: 2024-12-06

3,5-di-tert-butylcatechol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,5-Di-tert-butylcatechol (3,5-DTBC) is a hindered phenol that is commonly used as an antioxidant. It is synthesized by the reaction of tert-butyl alcohol with catechol in the presence of an acid catalyst. 3,5-DTBC is a highly effective antioxidant due to its steric hindrance, which prevents it from undergoing autoxidation. It is used in a variety of applications, including as a stabilizer for polymers, oils, and fats. It is also used in the pharmaceutical industry as an antioxidant in drug formulations. 3,5-DTBC is studied extensively due to its wide range of applications and its effectiveness as an antioxidant.'

3,5-di-tert-butylcatechol: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID66099
CHEMBL ID1795400
SCHEMBL ID247483
MeSH IDM0152887

Synonyms (51)

Synonym
AKOS015837934
3,5-di-tert-butylcatechol
1, 3,5-di(1,1-dimethylethyl)-
1020-31-1
3,5-di-tert-butylpyrocatechol
3,5-di-t-butylcatechol
nsc-59767
pyrocatechol,5-di-tert-butyl-
nsc59767
4,6-di-tert-butylpyrocatechol
1, 3,5-bis(1,1-dimethylethyl)-
OPREA1_834691
1,2-benzenediol, 3,5-di(1,1-dimethylethyl)-
1,2-benzenediol, 3,5-bis(1,1-dimethylethyl)-
inchi=1/c14h22o2/c1-13(2,3)9-7-10(14(4,5)6)12(16)11(15)8-9/h7-8,15-16h,1-6h
3,5-di-tert-butylcatechol, 98%
3,5-ditert-butyl-catechol
3,5-ditert-butylbenzene-1,2-diol
D2432
A800501
3,5-ditert-butylbenzene-1,2-diol;3,5-di-tert-butylcatechol
CHEMBL1795400
pyrocatechol, 3,5-di-tert-butyl-
unii-1328kn3f8b
ccris 5827
nsc 59767
1328kn3f8b ,
einecs 213-816-9
3,5-di-tert-butylbenzene-1,2-diol
3,5-bis(tert-butyl)benzene-1,2-diol
FT-0614737
di-tert-butylcatechol, 3,5-
SCHEMBL247483
mfcd00008819
SY011188
DTXSID4061414
3,5-ditertiarybutylcatechol
3,5-di-t-butylcathechol
1,2-dihydroxy-3,5-di-tert-butyl benzene
3,5-bis(1,1-dimethylethyl)catechol
3,5-di-tert-butyl-1,2-benzenediol
3,5-di-tert-butyl-1,2-dihydroxybenzene
W-108890
PS-7820
1,2-benzenediol,3,5-bis(1,1-dimethylethyl)-,labeled with oxygen-18(9ci)
F0001-0073
122983-47-5
Q27251465
CS-0154919
EN300-77174
Z1192367739
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID602812Inhibition of Sarcoplasmic/endoplasmic reticulum calcium ATPase in rabbit hind leg tissue microsomes assessed as rate of NADH oxidation coupled to SERCA-catalyzed ATP hydrolysis by spectroscopic assay2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Discovery of novel SERCA inhibitors by virtual screening of a large compound library.
AID602814Inhibition of Sarcoplasmic/endoplasmic reticulum calcium ATPase in rabbit hind leg tissue microsomes assessed as inorganic phosphate release by malachite green dye based chromogenic assay2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Discovery of novel SERCA inhibitors by virtual screening of a large compound library.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (3.03)18.7374
1990's0 (0.00)18.2507
2000's16 (48.48)29.6817
2010's14 (42.42)24.3611
2020's2 (6.06)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.96

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.96 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index5.73 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.96)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other34 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]